Overall prescribing trends The study found that 1,162,662 patients were prescribed a GLP-1 RA between January 2018 and June 2024, with 4,815,135 total prescriptions during this period
BPC-157s counter-regulatory NO modulation provides anti-inflammatory effects without complete immunosuppression
Summary Keywords glucagon-like peptide 1 receptor agonist, type 2 diabetes, cardiovascular, safety, semaglutide Citation Nauck MA and Quast DR (2021) Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6
It is the first time the FDA has offered that fast-tracking to any psychedelics
Pyrosequencing reveals bacterial communities in unchlorinated drinking water distribution system: an integral study of bulk water, suspended solids, loose deposits, and pipe wall biofilm